Edition:
India

Zosano Pharma Corp (ZSAN.OQ)

ZSAN.OQ on NASDAQ Stock Exchange Capital Market

4.35USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$4.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,281
52-wk High
$60.00
52-wk Low
$3.63

Select another date:

Tue, Feb 13 2018

BRIEF-Zosano Pharma Files Prospectus Related Offering 12.5 Mln Shares

* ZOSANO PHARMA CORP FILES PROSPECTUS RELATED OFFERING 12.5 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text: (http://bit.ly/2EDTBag) Further company coverage:

BRIEF-Zosano Pharma Files Prospectus Related To 10 Mln Stock Offering

* ZOSANO PHARMA CORP FILES PROSPECTUS RELATED TO OFFERING 10 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING‍​ Source text (http://bit.ly/2GUOzEr) Further company coverage:

BRIEF-Zosano Pharma Files For Offering Of Up To $57.5 Million Shares

* ZOSANO PHARMA FILES FOR OFFERING OF UP TO $57.5 MILLION SHARES - SEC FILING Source text :[http://bit.ly/2BPJFqj] Further company coverage:

BRIEF-Zosano Pharma Says Board To Reduce Size To Five

* ZOSANO PHARMA SAYS BOARD OF DIRECTORS ADOPTED A RESOLUTION TO REDUCE SIZE OF BOARD TO FIVE DIRECTORS - SEC FILING Source: (http://bit.ly/2j7YwDM) Further company coverage:

BRIEF-Zosano pharma Q3 loss per share $0.20

* Zosano pharma reports third quarter 2017 financial results and operational update

BRIEF-Zosano Pharma announces initiation of long-term safety study for M207

* Zosano Pharma announces initiation of long-term safety study for M207 as an acute treatment of migraine Source text for Eikon: Further company coverage:

BRIEF-Zosano enters into common stock purchase agreement with Lincoln Park Capital

* Zosano enters into common stock purchase agreement with Lincoln Park Capital Source text for Eikon: Further company coverage:

BRIEF-Zosano appoints Kenneth Greathouse to board of directors

* Zosano appoints Kenneth Greathouse to board of directors Source text for Eikon: Further company coverage:

BRIEF-Zosano provides patent application update

* Zosano Pharma Corp - Received official written notification of an office action from U.S. patent and trademark office

Select another date: